Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT (PREVENT)

March 21, 2018 updated by: Marilyn MacKay-Lyons

Effectiveness of a Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke: A Multi-site RCT

The objective of the Program of Rehabilitative Exercise and Education to avert Vascular Events after Non-disabling stroke and Transient ischemic attack (PREVENT) Trial is to determine whether the timely delivery of secondary stroke prevention strategies will reduce modifiable vascular risk factors in two groups of people who have survived NDS or TIA. One group will receive a comprehensive education and exercise program (PREVENT); the other group will receive usual care (USUAL CARE). We will measure modifiable vascular risk factors in both groups. We will also compare the effects of PREVENT vs USUAL CARE on exercise capacity, walking endurance, and daily physical activity. In addition, we will compare thinking ability, depression, achievement of personal goals for healthy behavior, and health-related goal attainment and health-related quality of life. Finally, we will compare outcomes in urban and rural settings as well as costs of the PREVENT program and USUAL CARE in order to assess sustainability of the PREVENT program.

Study Overview

Study Type

Interventional

Enrollment (Actual)

187

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 3A7
        • Halifax Infirmary Site, QEII Health Sciences Centre
      • Kentville, Nova Scotia, Canada, B4N 5E3
        • Annapolis Valley Regional Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and females
  • Over 17 years of age.
  • Diagnosis of first probable or definite TIA or non-disabling stroke (National Institutes of Health Stroke Scale < 6)
  • Post-event interval of <90 days.
  • Residence within 75 km of intervention site.
  • Orientation to time, place and person and ability to follow simple 3-step commands.
  • Ability and willingness to provide informed consent.

Exclusion Criteria:

  • Evidence of intracranial hemorrhage on MRI or CT scan.
  • Presence of contraindications to exercise testing and training, in accordance with American College of Sports Medicine Guidelines.
  • Participation in another study that could potentially confound the outcomes of this trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PREVENT program
12-week program of exercise and education to induce physiological and behavioral changes needed to reduce vascular risk factors.
12-week program of aerobic/strengthening exercises and education designed to induce physiological and behavioral changes deemed necessary to reduce vascular risk
ACTIVE_COMPARATOR: Usual Care
Average of three visits to the Neurovascular Clinic for a neurological and health assessment, counseling regarding stroke/TIA and diagnostic test results, and assessment, modification and education of secondary prevention factors
Three or more out-patient visits to the neurovascular clinic for assessment, counseling and referral to appropriate health care professionals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
systolic blood pressure (primary vascular risk factor being assessed)
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
diastolic blood pressure
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
waist circumference
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
12-hour fasting lipid profile
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
12-hour fasting glucose/hemoglobin A1C
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
exercise capacity
Time Frame: baseline, post-intervention, 12 months
baseline, post-intervention, 12 months
daily physical activity
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
walking endurance
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
cigarette smoking
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
medication adherence
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
cognition
Time Frame: baseline, 12 months
baseline, 12 months
depression
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
health-related quality of life
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
health-related goal attainment
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
direct health costs
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
secondary vascular events
Time Frame: baseline, post-intervention, 6 months, 12 months
baseline, post-intervention, 6 months, 12 months
daily step count
Time Frame: baseline, post-intervention, 12 months
baseline, post-intervention, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 30, 2011

Primary Completion (ACTUAL)

June 30, 2017

Study Completion (ACTUAL)

June 30, 2017

Study Registration Dates

First Submitted

April 21, 2009

First Submitted That Met QC Criteria

April 21, 2009

First Posted (ESTIMATE)

April 22, 2009

Study Record Updates

Last Update Posted (ACTUAL)

March 23, 2018

Last Update Submitted That Met QC Criteria

March 21, 2018

Last Verified

March 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe